Invo Bioscience Inc Expected To Post A Loss Of 22 Cents A Share: Earnings Preview

INVO Fertility

29/03/2022 21:08

* INVO Bioscience Inc  INVO.OQ   INVO.O  is expected to show
a
rise in quarterly revenue when it reports  results on March 31. 
    * The Lakewood Ranch Florida-based  company is expected to
report 
a 6.7% increase in revenue to $209.67 thousand from $196.57
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for INVO Bioscience Inc
is
for a loss of 22 cents per share. For the same quarter last
year, the company reported a loss of 60 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INVO
Bioscience
Inc is $6​, above​ its last closing price of $2.75. ​​​

This summary was machine generated March 29 at 20:08 GMT.  All
figures in US dollars  unless otherwise stated